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ttp://dx.doi.org/10.1016/j.ajpath.2015.01.022The integrity of the lung alveolar epithelial barrier is required for the gas exchange and is important for
immune regulation. Alveolar epithelial barrier is composed of ﬂat type I cells, which make up approxi-
mately 95% of the gas-exchange surface, and cuboidal type II cells, which secrete surfactants and
modulate lung immunity. p120-catenin (p120; gene symbol CTNND1) is an important component of
adherens junctions of epithelial cells; however, its function in lung alveolar epithelial barrier has not been
addressed in genetic models. Here, we created an inducible type II cellespeciﬁc p120-knockout mouse
(p120EKO). The mutant lungs showed chronic inﬂammation, and the alveolar epithelial barrier was leaky
to 125I-albumin tracer compared to wild type. The mutant lungs also demonstrated marked inﬁltration of
inﬂammatory cells and activation of NF-kB. Intracellular adhesion molecule 1, Toll-like receptor 4, and
macrophage inﬂammatory protein 2 were all up-regulated. p120EKO lungs showed increased expression
of the surfactant proteins Sp-B, Sp-C, and Sp-D, and displayed severe inﬂammation after pneumonia
caused by Pseudomonas aeruginosa compared with wild type. In p120-deﬁcient type II cell monolayers,
we observed reduced transepithelial resistance compared to control, consistent with formation of
defective adherens junctions. Thus, although type II cells constitute only 5% of the alveolar surface area,
p120 expressed in these cells plays a critical role in regulating the innate immunity of the entire lung.
(Am J Pathol 2015, 185: 1251e1263; http://dx.doi.org/10.1016/j.ajpath.2015.01.022)Supported by CAPES fellowship (Coodernação de Aperfeiçoamento de
Pessoal de Nível Superior) from Brazil (A.Z.C.); NIH grants HL105947-01
(Y.L.), HL07829-16 (A.B.M.), HL090152 (A.B.M.); and the Department of
Pharmacology, University of Illinois College of Medicine, Chicago.
Disclosures: None declared.Lungs are constantly exposed to pathogens; therefore, a
highly restrictive alveolar epithelial barrier and ﬁnely tuned
host defense mechanisms are indispensable for their protec-
tion.1,2 Unchecked inﬂammation is linked to various acute
and chronic diseases, including edema, acute respiratory
distress syndrome, and ﬁbrosis.3,4 Although it is abundantly
clear that the alveolar epithelial barrier regulates the transport
of gases, liquid, and ions,5,6 the role of the barrier in the
regulation of the innate immune function of lungs remains
poorly understood.
The restrictiveness of the alveolar epithelial barrier is
dependent on a series of interacting proteins comprising the
adherens junctions (AJs) and tight junctions (TJs).7,8 The
core of the epithelial AJs is composed of E-cadherin, which
links cells to one another in the monolayer.9 The cyto-
plasmic domain of E-cadherin associates with a-catenin,stigative Pathology.
.b-catenin, and p120-catenin (p120, ofﬁcial name catenin delta
1; CTNND1).9 The a- and b-catenins can recruit proteins that
link E-cadherin to the actin cytoskeleton,9 and together, these
interactions maintain the tension landscape in the epithelial
monolayer.10 b-Catenin also plays an essential role in the Wnt
signaling pathway and thereby contributes to cell proliferation
and differentiation.11 However, p120 has received compara-
tively less attention, although recent studies have shown that
p120 has important functions in regulating cadherin stability
and turnover12 and innate immunity.13
Table 1 Sequences of the Primers Used in This Study
Primer name Forward primer Reverse primer
p120 30loxP 50-TTTTAGAGCCTCCCACATACAAGC-30 50-TCAGCACCCACACAAAGGTTG-30
p120 5’loxp 50-TTGAACTCAGGACCGTCAGAGGAG-30 50-AAAGCAAGCCACCACCAACC-30
TetO-Cre 50-GCGGCATGGTGCAAGTTGAAT-30 50-CGTTCACCGGCATCAACGTTT-30
Spc-rtTA 50-GACACATATAAGACCCTGGTCA-30 50-AAAATCTTGCCAGCTTTCCCC-30
MIP2 50-GAACATCCAGAGCTTGAGTGTGA-30 50-CTTGAGAGTGGCTATGACTTCTGTC-30
ICAM 50-TCACCAGGAATGTGTACCTGAC-30 50-GGCTTGTCCCTTGAGTTTTATG-30
SPA 50-AGGCAGACATCCACACAGCTT-30 50-ACCAGTGGTTTCTCCCAATCAC-30
SPB 50-GGAACACCAGTGAACAGGCTATG-30 50-AAACTGTTCACACTTTTGCCTGTCTA-30
SPC 50-GCCTTCTCATCGTGGTTGT-30 50-CCAGTATCATGCCCTTCCT-30
SPD 50-CCAACAAGGAAGCAATCTGACAT-30 50-CAAGACAAGCATGGAGAGAAAGG-30
CLO 50-CTTGTCCATGGCAAATGCTG-30 50-TGATCTTCTTGCTGGTCTTGC-30
TLR4 50-AGTGGGTCAAGGAACAGAAGCA-30 50-CTTTACCAGCTCATTTCTCACC-30
AQP5 50-GCCACCCTCATCTTCGTCTTCTTT-30 50-TGGTTGCCTATTAAGAGGGCCAGA-30
Chignalia et alHere, we focused on the role of p120 expressed in alveolar
epithelial type II cells in regulating the innate immune
function of lungs. Although alveolar type II cells cover only
5% of the alveolar surface area, these cells are metabolically
active.14 They produce surfactants, serve as facultative pro-
genitor cells to repair alveolar injury, and regulate innate
immune function of the lung.14 These cells express Toll-like
receptors (TLRs) and tumor necrosis factor receptors.15 In-
teractions with pathogens or endotoxins activate these re-
ceptors to initiate NF-kB signaling to produce tumor necrosis
factor,16 IL-1 and IL-6,16 regulated on activation normal T
cell expressed and secreted,17 and chemokine C-X-C motif
ligand 1.18 These factors play key roles in recruiting in-
ﬂammatory cells.19e21 Alveolar type II cells also secrete the
surfactant proteins (Sp)-A, -B, -C, and -D,22 which regulate
innate and adaptive immunity by binding to antigen through
interactions with surface receptors on inﬂammatory cell
membranes.23 Here, we studied the function of p120 through
disrupting the p120 gene in alveolar type II cells in mice
using the rtTA/TetO system coupled with a type II celle
speciﬁc SPC promoter. In these mice, we observed unchecked
chronic lung inﬂammation associated with increased NF-kB
activity and a persistently leaky alveolar epithelial barrier.
These results provide the ﬁrst genetic evidence that p120 in
type II cells is a central regulator of innate immunity of lungs.Materials and Methods
Mouse Strains
The animal experiments were approved by the Animal Care
Committee and Institutional Biosafety Committee of the
University of Illinois at Chicago. The SPC-rtTA/TetO-Cre/
p120loxP mouse line is homozygous for the p120loxP
locus and harbors the transgenes SPC-rtTA and TetO-
Cre.24e26 This line is designated here as p120EKO and was
maintained on a mixed C57/FVB genetic background. For
doxycycline (Dox)-induced type II alveolar cellespeciﬁc
disruption of the p120 gene, mice were fed with a Dox diet1252(Teklad, Dox concentration 625 mg/kg; Harlan Labora-
tories, Inc./Harlan Teklad, Madison, WI) for 15 days. In our
study, mutant genotype refers to SPC-rtTA/TetO-Cre/
p120loxP, whereas the control genotype [wild-type (WT)]
refers to þ/TetO-Cre/p120loxP or SPC-rtTA/TetO-Cre/þ.
Control and mutant mice were fed with the Dox diet for
15 days and then fed normal food for 3 to 7 weeks before
experiments as indicated later. Each experiment was made
with paired mutant and control mice of the same age and
sex. Genotype was determined by standard PCR. Primers
used for genotyping are listed in Table 1.
Western Blotting
Freshly isolated lungs or cells were homogenized in lysis
buffer [50 mmol/L phosphate buffer (pH 7.4); 2 mmol/L
EDTA; 5 mmol/L EGTA; 1% Triton X-100] supplemented
with leupeptin, pepstatin, aprotinin, sodium orthovanadate,
and phenylmethylsulfonyl ﬂuoride. Proteins were extracted,
and the lysate protein concentration was determined by the
Bradford method using Bio-Rad Protein Assay Kit (Bio-Rad
Laboratories, Hercules, CA). Proteins (50 mg) were separated
by electrophoresis and transferred to a polyvinylidene
diﬂuoride membrane. Nonspeciﬁc binding sites were blocked
with 5% skim milk in Tris-buffered saline solution with 1%
Tween-20 for 1 hour at room temperature. Membranes were
incubated with speciﬁc primary antibodies. After incubation
with appropriate secondary antibodies (peroxidase-conjugated),
signals were revealed with chemiluminescence (Bio-Rad
Laboratories), visualized by autoradiography, and quantiﬁed
densitometrically by ImageJ version 1.48 (NIH, Bethesda,
MD). Values were normalized for expression of b-actin, and
results are expressed as percentages of control samples.
Immunohistochemistry
Lungs were isolated as previously described,26 ﬁxed with 4%
paraformaldehyde in PBS at 4C overnight, and forwarded for
parafﬁn embedding and sectioning in the Research Histologyajp.amjpathol.org - The American Journal of Pathology
Function of Type II Cell p120and Tissue Imaging Core (University of Illinois at Chicago).
Sections were deparafﬁnized by xylene and rehydrated by serial
dilution of ethanol, blocked with 10% donkey or goat normal
serum in PBS before antibody staining. Antibodies were
used as follow: antieSp-A (Chemicon, Billerica, MA),
antieSp-B (Millipore, Billerica, MA), antieSp-C (Santa
Cruz Biotechnology, Dallas, TX), antieSp-D (Chemicon),
antieb-actin (Santa Cruz Biotechnology), antiephospho-
p65 (Cell Signaling Technology, Danvers, MA), anti-p65
(Santa Cruz Biotechnology), antieE-cadherin (Millipore),
anti-p120 (kindly provided by Dr. Albert B. Reynolds,
Vanderbilt University Medical Center, Nashville, TN),
anti-zona occludens-1 (ZO-1; Invitrogen, Carlsbad, CA),
and anti-T1a (Developmental Studies Hybridoma Bank
under the auspices of the National Institute of Child Health
and Human Development). Concentrations were used as
recommended by the manufacturers.
RT-qPCR
Real-time-PCR was performed as described.26 RNA was
extracted by TRIZOL (Invitrogen), treated by DNase I
(Qiagen, Valencia, CA), and puriﬁed with an RNeasy kit
(Qiagen). Real-time RT-PCR was performed using a
QuantiTect SYBR Green RT-PCR kit (Qiagen) and the ABI
Prism 7000 Sequence Detection System (Applied Bio-
systems, Carlsbad, CA). Primers were obtained from
Integrated DNA Technologies (Coralville, IA) and are listed
in Table 1. Data were analyzed using the comparative cycle
threshold (CT) method. Relative quantiﬁcation to the control
sample calibrator was calculated using the formula 2(DDCT).
Gene expression was normalized to the level of cyclophilin,
which was used as an internal control.26,27 Data are pre-
sented as relative expression levels compared with WT.
Alveolar Type II Cell Isolation and Culture
Alveolar type II cells were isolated as previously
described.26,28 Animals were anesthetized with ketamine/
xylazine mixture and exsanguinated. Lungs were washed with
20 mL of PBS through the pulmonary artery. Dispase (2 mL;
BD Biosciences, San Jose, CA) was injected intratracheally,
followed by 0.5 mL of 2% melted agarose in PBS at approx-
imately 50C. Ice was placed on top of the lungs immediately
after agarose injection to allow its polymerization. Lungs were
then isolated and incubated with dispase for 1 hour at room
temperature. Lungs were mechanically dissected in DMEM
containing 100 U/mLDNase (Sigma-Aldrich, St. Louis, MO).
Dissociated cells were collected by centrifugation (6 minutes,
150  g, room temperature) and incubated for 1 hour (37C,
5% CO2) in plates coated with anti-CD32 and anti-CD45 an-
tibodies (eBioscience, SanDiego, CA). Cells were panned and
collected by centrifugation (6 minutes, 150  g, room tem-
perature). The purity of type II cells was assessed by a modi-
ﬁed Papanicolaou stain,28 and only preparations with >90%
purity were used for subsequent experiments.The American Journal of Pathology - ajp.amjpathol.orgBAL Fluid Analysis
Bronchoalveolar lavage (BAL) ﬂuid was collected, and
protein and cell concentrations were analyzed as previ-
ously described.26 Approximately 1 mL of BAL was
collected for each mouse, and protein concentration was
determined by the Bradford method using the Bio-Rad
Protein Assay Kit. Cells in BAL were quantiﬁed using a
hemocytometer (Fisher Scientiﬁc, Hanover Park, IL). Cells
were immobilized on Superfrost Plus microscope slides
(Fisher Scientiﬁc) by cytospin centrifugation (5 minutes,
50  g, room temperature) and stained to visualize the
shape of nucleus using a Hema 3 staining kit (Fisher Sci-
entiﬁc) as previously described.26 Concentration of albumin
in the BAL was assessed using Albumin Blue Fluorescent
Assay Kit (Active Motif, Carlsbad, CA) according to the
manufacturer’s instructions.
TEER Measurement
Transepithelial electrical resistance (TEER) was determined
using the Electric Cell Substrate Impedance Sensing system29
(Applied Biophysics, Troy, NY). Alveolar type II cells were
isolated and cultured to conﬂuence on gelatin-coated culture
chambers with electrodes (8W10Eþ electric cell-substrate
impedance sensing [ECIS] plates; Applied Biophysics). The
resistance of the cultured cells was measured at an AC fre-
quency of 4000 Hz and deducted by the naked electrode
resistance. A 4000-Hz frequency was used to ensure that more
current would go through the cellecell junction.30,31 TEER
was calculated bymultiplying the resistance by the surface area
of the electrode.
In Vivo Alveolar Barrier Permeability Measurement
The permeability assay was modiﬁed from previously
described methods.32 WT and p120EKO mice at 7 weeks
post-Dox treatment were anesthetized in a bell jar with 2.5%
isoﬂurane in room air supplied at 2 L per minute. After
induction, anesthesia was continued by means of a nose
cone, and a tracheotomy was performed. The trachea was
rapidly cannulated for ventilation of the lung with the
anesthetic gas mixture (peak inspiratory pressure 12 cm
H2O, positive end-expiratory pressure 2 cm H2O, frequency
120 min1). Heparin (50 U) was injected into the jugular
vein for anticoagulation. The pulmonary artery and the left
atrium were cannulated with custom-made glass cannulae
(Radnoti, Monrovia, CA). Lungs were perfused in situ
through the pulmonary artery at constant ﬂow (1.6 to 1.8
mL per minute), temperature (37C), and venous pressure
(0 cm H2O) with ventilation continuing at a peak inspiratory
pressure of 14 cm H2O. The perfusing liquid consisted of
phenol redefree RPMI 1640 medium (Sigma-Aldrich)
supplemented with 1 g/100 mL bovine serum albumin
(Fraction V, 99% pure and endotoxin-free; Sigma-Aldrich).
The perfusate ﬂow rate was measured at the beginning of1253
Figure 1 Type II cellespeciﬁc disruption of p120 in mice. A: Schematic diagram showing the type II cellespeciﬁc deletion system for disrupting
p120. The rtTA protein is produced from a type II cellespeciﬁc surfactant protein (Sp)-C promoter. After interacting with doxycycline (Dox), rtTA
induces the production of Cre recombinase from the tetO site in type II cells. Cre then disrupts p120 through the two loxP sites ﬂanking introns 2 to 8
of the p120 gene. B and C: Western blot analysis using type II cells isolated from wild-type (WT; black bars) or p120EKO (white bars) lungs at 3 weeks
(B) and 7 weeks (C) post-Dox treatment. Relative expression levels of p120 were quantiﬁed by measuring signal intensities and normalizing to b-actin
level. DeK: Lung sections from WT and p120EKO mice at 7 weeks post-Dox treatment were stained with antibodies to Sp-C, T1a, and p120. E, G, I, and
K are enlarged images of the boxed areas in D, F, H, and J, respectively. DeG: Lung sections were stained with Sp-C (red) and p120 (green). p120
expression is present in Sp-Ceexpressing cells in WT lungs (arrows in D and E), but is absent in Sp-Cþ cells in p120EKO lungs (arrows in F and G). HeK:
p120 is not deleted in cells that expressed T1a (pink, arrowheads) in both WT (H and I) and p120EKO (J and K) lung sections. Data points are
presented as means  SEM as a percentage of control (WT) (B and C). Data are representative of two independent observations (DeK). n Z 3 mice per
group (B); n Z 6 mice (C). *P < 0.05 versus WT. Scale bar Z 10 mm.
Chignalia et aleach experiment by collecting and weighing the venous
efﬂuent.
The tracheal cannula had a concentric design permitting
ventilation through an 18-Ga stainless-steel tube and intra-
tracheal instillation via an indwelling PE10 tube, whose
position was adjustable. After an equilibration perfusion of 30
minutes, the ventilator was turned off, which caused the lung
to collapse. The PE10 tube was advanced to the bifurcation of
the main bronchus, and secured to the distal trachea with a
ligature to prevent instillate back ﬂow. 125I-lableled human
serum albumin (0.25 to 0.5 mCi; Anazao Health Corp., Tampa,1254FL) in 0.4 mL of RPMI, supplemented with 0.3 mg/mL Evans
Blue dye as a distribution marker, was instilled into the lung at
a rate of 0.2 mL per minute with the aid of a syringe drive.
Because the instilled volume of 0.4 mL is comparable to the
normal tidal volume in an adult mouse, the instillate in most
cases uniformly re-expanded the lung; an additional 0.1 mL of
air was injected via the inner tube to clear the dead space. Only
lung preparations exhibiting a uniform light blue color
(indicative of even tracer distribution) were used.
Immediately after completing the instillation protocol,
pulmonary venous efﬂuent samples (volume 1.5 to 2.0 mL)ajp.amjpathol.org - The American Journal of Pathology
Figure 2 Inﬂammatory phenotype of lungs from p120EKO mice. A and B: Mice were subjected to bronchoalveolar lavage (BAL). p120EKO lungs display
increased total numbers of cells (A) and a greater ratio of neutrophils to total cells (B) in BAL. C: p120EKO lung lysates show augmented myeloperoxidase
(MPO) activity compared with wild-type (WT) lung lysates. D: Lungs were processed for Western blotting for phospho-NF-kBp65 and total NF-kBp65. E: The
mutant lungs showed an enhanced ratio of phospho-p65 to total p65, as quantiﬁed by measuring band intensities by Western blot analysis. FeH: Quantitative
RT-PCR using WT and mutant whole-lung RNA shows higher macrophage inﬂammatory protein-2 (MIP-2; F), intercellular adhesion molecule 1 (ICAM1; G), and
Toll-like receptor 4 (TLR4; H) mRNA levels in mutant lungs compared with WT lungs. I and J: Western blot analysis using whole-lung lysates shows that ICAM1
protein levels are increased in mutant lungs compared with WT lungs. Data points indicate the means  SEM. nZ 3 to 8 mice per group (AeC, EeH, and J).
*P < 0.05, **P < 0.01 versus WT.
Function of Type II Cell p120were collected into stoppered tubes at 10-minute intervals
for 60 minutes. The radioactivity in the venous efﬂuent
samples, instillate, and lung tissue was determined with the
aid of a gamma counter (Model 2470; Perkin-Elmer,
Shelton, CT). Tracer albumin permeabilityesurface area
product (PS) was calculated for each time point by
PSZ Solute flux=ðCas  CperfÞ; where Cas and Cperf are
the concentrations of albumin tracer [counts per minute
(cpm)] in airspace ﬂuid and perfusing liquid, respectively,
and solute ﬂux was calculated from the slope of the tracer
efﬂux curve (cpm) since the preceding sample. Cas (cpm/
mL) was calculated from the ratio of tracer counts
remaining in the lung at each time point and the instilled
volume (mL). This volume was estimated as total instilled
tracer counts at zero time divided by the measured tracer
concentration (cpm/mL) in an instillate sample. PS values
were stable after 30 minutes, and the PS product for each
lung preparation was calculated from the slope of the tracer
efﬂux curve between 40 and 60 minutes. PS is reported in
units of nL per minute.Mean Linear Intercept Calculation
The mean linear intercept was calculated as previously
described using sections stained with hematoxylin andThe American Journal of Pathology - ajp.amjpathol.orgeosin.33,34 Brieﬂy, two lines of the same known length were
crossed in a microscopic ﬁeld of a lung section. Ten ﬁelds
were measured. Every time the transverse crossed an alveolar
wall, a single intercept was counted. A cut in or out of a blood
vessel was counted as half of an intercept. The number of
intercepts was counted in both vertical and horizontal lines.
The mean linear intercept was calculated by the formula
Lm Z N  L=m; in which L is the length of the transverses,
m is the sum of all intercepts, and N is the number of times the
transverses are placed on the lung.
Pseudomonas aeruginosaeInduced Pneumonia in Mice
Pseudomonas aeruginosa (strain 103) was prepared as
described.26 Mice were challenged with P. aeruginosa
through intratracheal instillation. Each mouse was injected
with 2  104 live P. aeruginosa mixed with 2  106 dead
P. aeruginosa. Dead P. aeruginosa was generated by stor-
age at 20C for 1 week.
Statistics
Each data point is presented as the means  SEM. Differ-
ences between groups were tested for statistical signiﬁcance
using a t-test. P < 0.05 was considered statistically
signiﬁcant.1255
Figure 3 Leakiness of alveolar epithelial barrier in p120EKO mice. A: Type II cells were freshly isolated from 7 weeks post-doxycycline (Dox)-treated wild-
type (WT) and p120EKO mice, and expression levels of E-cadherin in these cells were assessed by Western blot analysis. b-actin level was used as loading
control. E-cadherin levels were not quantiﬁed because of the extremely faint signal for mutant cells. B: Post-Dox treatment mice subjected to bronchoalveolar
lavage (BAL) analysis show increased BAL protein concentrations in the mutant. CeE: In vivo trans-alveolar epithelial 125I-albumin permeability assay. C: A
schematic diagram showing the experimental model. Mouse lungs were isolated under anesthesia and ventilated; next, 125I-albumin (125I-bovine serum
albumin) was injected intratracheally. Lungs were also perfused with RPMI from the pulmonary artery (PA), and efﬂuent was collected in the pulmonary vein
(PV). The trans-alveolar epithelial ﬂux of 125I-albumin was recorded by measuring the radioactivity of venous efﬂuent at different time points. D: Repre-
sentative tracer washout curves in lungs of WT and p120EKO mice. E: 125I-albumin permeabilityesurface area product (PS) is a measurement of lung alveolar
epithelial protein permeability and was calculated from the slope of the washout curve at 40 to 60 minutes. PS was found to be approximately 90 nL per minute
in control mice and approximately 220 nL per minute in the mutant mice. F: Albumin levels increased in lavage ﬂuid of p120EKOmice. Data points indicate the
means SEM (B, E, and F). Data are representative of three independent experiments (A). nZ 3 to 8 mice per group (D and E); nZ 5 to 6 mice per group (F).
*P < 0.05, **P < 0.01 versus WT.
Chignalia et alResults
Alveolar Type II CelleSpeciﬁc Deletion of p120 in Mice
We used the SPC-rtTA/TetO-Cre/p120EKO mouse line
to speciﬁcally disrupt the p120 gene in type II cells.
Expression of Cre recombinase was activated in alveolar
type II cells in adult mice by the Dox-inducible rtTA/TetO
system coupled with a type II cellespeciﬁc promoter,
SPC.24e26 Cre recombinase mediates the disruption of
p120 through the loxP sites that ﬂank introns 2 to 8 of the
p120 gene (Figure 1A).25 The Dox-inducible system
enabled the disruption of p120 speciﬁcally in type II cells
of adult mouse lungs. Previous studies indicated that
approximately 70% of type II cells expressed Cre
recombinase in this system.26 We found that p120 protein
expression in mutant type II cells freshly isolated from
p120EKO mouse lungs was not changed at 3 weeks after
Dox treatment (Figure 1B) but was signiﬁcantly
decreased at 7 weeks post-Dox treatment (Figure 1C and
Supplemental Figure S1). The delayed disruption of p120
may reﬂect the slow turnover rate of p120 protein and/1256or type II cells themselves.14,35 Immunohistochemistry
showed that, although the disruption of p120 expression
occurred in type II cells, expression in other cell types, such as
type I cells, was unchanged (Figure 1, DeK). Because p120
protein levels were decreased after 7 weeks post-Dox treatment,
all of the following experimental analyses were performed at
this time point.Severe Lung Inﬂammatory Phenotype of p120EKO Mice
We ﬁrst analyzed BAL isolated from control and p120EKO
mice at 7 weeks post-Dox treatment. BAL from mutant mice
showed an increased total cell count (Figure 2A) and a
higher ratio of neutrophils to the total cell number
(Figure 2B). To conﬁrm the observed inﬂammatory
phenotype, we measured myeloperoxidase activity36 and
found that the lung lysates from p120EKO mice had
signiﬁcantly increased myeloperoxidase levels compared
with WT mice (Figure 2C). Assays for NF-kB activity were
performed on whole lung lysates by comparing the ratio of
phospho-p65 to total p65. This assay showed that p120EKOajp.amjpathol.org - The American Journal of Pathology
Figure 4 Reduced transepithelial resistance
(TEER) and defective adherens junctions in p120-
deﬁcient type II cells. A: Alveolar type II cells
were freshly isolated from wild-type (WT) and
p120EKO mice and cultured until the cells formed a
conﬂuent monolayer. B and C: Type II cells from
WT and p120EKO mice were cultured on gelatin-
coated gold electrodes for TEER measurement. B:
TEER was measured at different time points be-
tween 80 and 140 hours after culture initiations.
Note that TEER values reached a plateau at 110
hours after starting culture. C: TEER measured at
110 hours after culture initiation. D and E: Alve-
olar type II cells isolated from WT and p120EKO
mice were cultured and stained for p120, E-cad-
herin, and zona occludens-1 (ZO-1). D: Cells in
which p120 was depleted do not show E-cadherin
staining (arrows). E: Cells in which p120 was
disrupted show normal ZO-1 staining (arrows).
Data are presented as means  SEM. n Z 3 to 4
mice per group (B); nZ 4 to 6 mice per group (C).
Data are representative of two independent ob-
servations (D and E). *P < 0.05 versus WT. Scale
bars: 10 mm (A); 5 mm (D and E).
Function of Type II Cell p120lungs had increased NF-kB activity compared with WT
lungs, whereas the amount of total p65 did not show a
change (Figure 2, D and E). Transcript levels of several
proinﬂammatory targets downstream of NF-kB were also
increased in p120EKO lungs, including macrophageThe American Journal of Pathology - ajp.amjpathol.orginﬂammatory protein-2 (MIP-2 or CXCL2) (Figure 2F),
intercellular adhesion molecule 1 (ICAM1) (Figure 2G),
and TLR4 (Figure 2H). Because ICAM1 is an important
mediator of neutrophil migration,37 we also showed by
Western blot analysis that ICAM1 protein expression was1257
Figure 5 Augmentedexpression of surfactant proteins (Sp)-B, -C, and -D in
p120EKO lungs. Lungs from control (black bars) and p120EKO (white bars) mice
wereprocessed for quantitative RT-PCR (AeD) andWesternblot (EeH) analysis.
AeD: The amount of Sp-A (A), Sp-B (B), Sp-C (C), and Sp-D (D) transcripts were
examinedbyquantitativeRT-PCR.EeH:Protein levels of Sp-A (E), Sp-B (F), Sp-C
(G), and Sp-D (H) were assessed by Western blot analysis. Expressions of Sp-A,
Sp-B, Sp-C, and Sp-D were normalized to b-actin expression and plotted as a
percentage of controls [wild type (WT)]. Data points indicate themeans SEM.
nZ 3 to 7 mice per group. *P < 0.05 versus WT.
Chignalia et alaugmented in p120EKO whole-lung lysates compared
with lysates from WT mice (Figure 2, I and J).
Because p120 was only disrupted in type II cells, we
isolated type II cells from WT and p120EKO lungs 7 weeks1258post-Dox and examined NF-kB signaling by Western blot
analysis and real-time PCR analysis. In contrast to the
results obtained using whole-lung lysates, p120EKO mutant
type II cells showed similar levels of NF-kB activity as WT
controls (Supplemental Figure S2A). Mutant type II cells
also expressed levels of TLR4, MIP-2, and ICAM1 tran-
scripts similar to WT cells (Supplemental Figure S2, BeD).
The expression level of ICAM1 protein in mutant type II
cells was slightly higher than WT, but the value was not
statically signiﬁcant (Supplemental Figure S2E). Thus, the
increase in NF-kB activity and MIP-2, ICAM1, and TLR4
expression (Figure 2, DeH) occurred nonautonomously in
other lung cells that retained normal p120 expression.
Deletion of Type II Cell p120 Disrupts Alveolar
Epithelial Barrier
Because p120 has been shown to stabilize E-cadherin at the
AJ,12 we examined the protein levels of E-cadherin in type II
cells freshly isolated fromWTand p120EKOmice byWestern
blot analysis. We found that there was a signiﬁcant reduction
of E-cadherin expression inmutant type II cells comparedwith
control (Figure 3A). Because E-cadherin is an important
component ofAJs,we next examinedwhether p120disruption
induced alveolar epithelial barrier defect. We found that
p120EKO lungs had a higher protein concentration in theBAL
(Figure 3B), suggesting severe leakage of capillaryealveolar
epithelial barriers. To assess alveolar epithelial permeability,
we measured transepithelial albumin ﬂux. Mouse lungs were
ventilated and perfused from the pulmonary artery to the
pulmonary vein, and 125I-labeled albumin was instilled
through the trachea (Figure 3C). The amounts of 125I-bovine
serum albumin that crossed the epithelial barrier at different
time points were measured by recording radioactivity in
venous efﬂuent samples. Permeability was determined by
calculating the tracer albumin PS. We observed greater PS in
mutant lungs comparedwithWT lungs (P< 0.05) (Figure 3,D
and E). Because the PS value can be affected by the surface
area, we estimated the alveolar surface area of WT and
mutant lungs by measuring the mean linear intercept value
from sections stained with hematoxylin and eosin that were
prepared from lungs of both genotypes.33,34 We found that
there was no signiﬁcant difference in either morphology
or mean linear intercept values between the WT and the
mutant (Supplemental Figure S3). Therefore, the epithelial
permeability of the mutant lung was signiﬁcantly increased
compared with WT.
To assess whether deletion of p120 from type II cells
could also lead to increased permeability in both endothelial
and epithelial barriers, we measured albumin concentration in
the BAL. Albumin BAL levels were signiﬁcantly increased in
lavage ﬂuid of p120EKO lung compared to WT (Figure 3F),
suggesting increased lung epithelial and vascular endothelial
permeability.
Next, we assessed whether p120 deletion in type II cells
interfered with their ability to form a restricted monolayerajp.amjpathol.org - The American Journal of Pathology
Figure 6 Severe inﬂammation in p120EKO lungs in mice with Pseu-
domonas aeruginosaeinduced pneumonia. Wild-type (WT; black bars)
and p120EKO (white bars) mice at 7 weeks post-doxycycline (Dox) were
injected with P. aeruginosa through intratracheal instillation, and in-
ﬂammatory responses were analyzed at 48 hours after the P. aeruginosa
challenge. A: Myeloperoxidase (MPO) activities were measured using
lung lysates. The data are plotted as the relative values compared to the
mean values of WTs in each independent experiment. B: Bronchoalveolar
lavage (BAL) was collected at 48 hours after P. aeruginosa, and numbers
of cells in BAL were counted. C and D: Hema 3 staining shows that most
cells from BAL of both WT (C) and mutant (D) were neutrophils. Data are
plotted as means  SEM (A and B). n Z 3 mice from two independent
experiments (A and B). *P < 0.05, **P < 0.01 versus WT. Scale
bar Z 20 mm (C and D).
Function of Type II Cell p120leading to exaggerated protein leak observed in In Vivo
Alveolar Barrier Permeability Measurement. Type II cells
were isolated from WT or p120EKO mice at 7 weeks post-
Dox treatment. Equal numbers of type II cells were cultured
on gold-plated electrodes, and real-time changes in TEER
were recorded by a method developed by Tiruppathi et al.29
This method used an AC current of 4000 Hz such that more
current goes through the cellecell junctions (paracellular)
rather than directly through the cell body (trans-
cellular).29e31 We grew cells for 110 hours until they
formed a conﬂuent monolayer (Figure 4A). We found from
the time course of recorded TEER change that in WT type II
cells, TEER rapidly increased until 110 hours after culture
initiation, after which it reached a plateau. However, TEER
values did not increase in p120-deﬁcient type II cells even
after 120 hours (Figure 4B). We also found that the ﬁnal
TEER of mutant type II cells was signiﬁcantly lower than
that of type II monolayers derived from WT lungs
(Figure 4C). These ﬁndings demonstrate that loss of p120
impaired the formation of restricted epithelial monolayer, ie,
increased epithelial permeability was retained in cultured
cells obtained from the mutant mice.
To examine cellecell adhesion in mutant alveoli epithe-
lial cells, we analyzed these cells by immunoﬂuorescence.
We stained for E-cadherin and ZO-1, major components ofThe American Journal of Pathology - ajp.amjpathol.orgAJs and TJs, respectively, in cultured type II cells isolated
from WT or p120EKO mice. The p120 mutant type II cells
showed decreased E-cadherin staining in cell junctions
(Figure 4D), consistent with Figure 3A and indicating a role
for p120 in stabilizing E-cadherin at AJs.12 By contrast, the
expression or localization of ZO-1 remained unaltered in
p120-deﬁcient cells (Figure 4E and Supplemental
Figure S4), indicating that p120 catenin deletion in alveoli
type II cells speciﬁcally altered AJs as opposed to TJs.
Augmented Production of Surfactant Proteins Sp-B,
Sp-C, and Sp-D in p120EKO Lungs
Because alveolar type II cellespeciﬁc p120 depletion could
induce lung inﬂammation by modulating the production of
surfactant proteins, we investigated whether the generation
of these proteins was altered in p120EKO lungs. We
observed by real-time PCR and Western blot analysis that
whole lung extracts showed no difference in Sp-A expres-
sion between p120EKO and WT mice (Figure 5, A and E),
whereas Sp-B, Sp-C, and Sp-D expression were increased in
p120EKO lungs compared with WT lungs (Figure 5, BeD,
and FeH). By culturing isolated WT and mutant type II
cells, and measuring Sp-D levels in the supernatant, we
observed that signiﬁcantly greater amounts of Sp-D was
produced by mutant type II cells compared with control
cells (Supplemental Figure S5).
Severe Inﬂammation in Response to P. aeruginosa
Pneumonia in p120EKO Mice
Because p120EKO lungs showed inﬂammatory phenotypes in
the unchallenged basal state, we further investigated whether
these mutants elicited severe inﬂammatory responses toward
lung injury induced by pneumonia. We used a P. aeruginosa
pneumonia model that we described earlier.26 At 48 hours
after P. aeruginosa administration, p120EKO lungs exhibited
increased myeloperoxidase activity compared with WT
(Figure 6A). BAL collected from the mutant lungs at this time
contained signiﬁcantly higher number of cells than control
(Figure 6B), and for both control and mutant, >95% of the
cells in BAL were neutrophils (Figure 6, C and D).
Deletion of p120 Spares Facultative Progenitor
Function of Type II Cells
Type II cells have the potential to serve as facultative pro-
genitor cells that proliferate and transdifferentiate into type I
cells14,35 To examine whether p120 plays a role in type II
cell progenitor activities, we isolated type II cells from
control and p120EKO lungs, and examined the transcription
levels of cyclin B1 and CDC25C, two factors that are
known to participate in type II cell proliferation.26 The
expression levels of these genes were not changed in the
mutant type II cells compared with WT (Figure 7, A and B).
The expression level of proliferating nuclear antigen in the1259
Figure 7 p120-disrupted type II cells show normal proliferation and
type II-to-I cell differentiation. AeC: Type II cells were isolated from
wild type (WT; black bars) and p120EKO (white bars) mice at 7 weeks
post-doxycycline (Dox) and analyzed by quantitative RT-PCR (A and B)
or Western blot analysis (C). Type II cells from p120EKO mice do not
show differences in the levels of mRNA for cyclin B1 (A) or CDC25C (B).
C: Proliferating nuclear antigen (PCNA) protein levels were compared
between WT and p120-deﬁcient type II cells. DeH: Type II cells were
isolated from mice at 7 weeks post-Dox and cultured. DeG: Type II
cells from both WT (D and F) and p120EKO lungs (E and G) were able to
differentiate into ﬂat type I-like cells at a similar time frame. F and G
are higher magniﬁcation of images D and E. H: After culture, p120-
deﬁcient type II cells had similar levels of Aqp5 mRNA compared to
WT cells, as accessed by quantitative RT-PCR. Data are presented as
means  SEM. Images are representative of more than three experi-
ments (DeG). n Z 4 to 6 mice per group (AeC and H). Scale bar Z 10
mm (DeG).
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1260mutant and WT type II cells was also similar (Figure 7C).
When control and mutant type II cells were cultured, both
differentiated into ﬂat type Ielike cells (Figure 7, DeG) and
expressed similar transcript levels of Aqp5, the type I cell
marker (Figure 7H).26Discussion
Here, we disrupted p120 speciﬁcally in alveolar epithelial
type II cells using the Dox-inducible Cre/loxP system.
Lungs from p120EKO mice manifested a defective epithe-
lial barrier, as indicated by increased trans-alveolar epithe-
lial albumin permeability and decreased TEER values
compared to controls. The mutant lungs also showed marked
inﬂammation, as was evident by augmented neutrophil inﬂux,
phosphorylation of NF-kB p65, and increased expression of
MIP-2, ICAM1, and TLR4. In addition, mutant type II cells
produced far greater amounts of surfactant proteins, especially
Sp-D. These results together showed that p120 expressed in
type II alveolar cells has a fundamental role in the regulation of
innate immune functions in the lung.
The inﬂammatory phenotype of p120EKO mice required
a period of 7 weeks post-Dox treatment to become apparent.
This timing correlated with decreased levels of p120 protein
in type II cells that appeared within this time frame. The
severity of the phenotype was also correlated with the
reduction of p120 levels. The delayed loss of p120 and
appearance of inﬂammatory phenotype likely reﬂects the
slow turnover rate of p120 protein and/or type II cells14,35
The consequences of disrupting p120-catenin in type II
cells appeared to be speciﬁc to certain type II cell functions
such as alveolar epithelial barrier, lung’s host defense, and
surfactant production, but p120 deletion had no effect on
type II cell proliferation and potential of type II cells to
differentiate into type I cells.
Although type II cells occupy only approximately 5% of the
alveolar surface area, it is surprising that type II celle
speciﬁc disruption of p120 caused such pervasive defects in
lung immunity and alveolar epithelial integrity. The level of
phospho-NF-kB and expressions of MIP-2, TLR4, and
ICAM1 mRNA were markedly increased in lungs from
p120EKO mice. The severity of the barrier leakiness might
result from both loss of AJs in type II cells and injury to the
epithelial barrier induced by the inﬂammation. Interestingly,
the TJs and ZO-1 expression appeared normal in mutant type
II cells, consistent with the effect of p120-catenin deletion in
the intestinal epithelium.38
The loss of alveolar epithelial barrier integrity might be
caused by defective stabilization of E-cadherin. p120 could
inhibit E-cadherin internalization because it binds to the
same C-terminal site on E-cadherin that binds to the clathrin
protein AP-1, thereby masking this endocytic signal.39 The
loss of E-cadherin in p120-deﬁcient type II cells is in accord
with this concept that E-cadherin was internalized and
degraded in the absence of p120. Thus, a likely scenario forajp.amjpathol.org - The American Journal of Pathology
Function of Type II Cell p120the severe lung inﬂammation seen in p120EKO mice is that
p120 ablation-induced E-cadherin instability caused a
breach in the alveolar epithelial barrier, resulting in the
inﬂux of antigens into alveoli, and the activation of lung
inﬂammation. The lung inﬂammation could indirectly in-
crease the permeability of endothelial barrier.40 In this
sense, p120 may be a crucial inﬂammation dampening
mechanism of the alveolar barrier. This is also evident from
our ﬁnding showing the mutant lungs had severely exag-
gerated inﬂammation response to P. aeruginosa pneumonia
as compared to WT.
In our study, to compare the transepithelial permeability of
WT and p120 mutant cells, we used the ECIS plates to
measure the TEER of type II cell monolayers. Our results
showed consistently that the TEER values of WT type II cell
monolayer were signiﬁcantly greater than that of p120-
depleted cells, indicating reduced barrier function of p120
mutant type II cells. The values obtained in our study were
lower than some previous measurements using Ussing
chamber systems,41e43 reﬂecting differences in methods
used. The discrepancy may be related to most of the current
passing through cellecell junctions (paracellular) rather than
passing the cell bodies (transcellular) in our ECIS sys-
tem,29e31 whereas the Ussing chamber approach cannot
distinguish these two kinds of currents.41e43 Second, in most
experiments using a Ussing chamber, the cells were cultured
on polycarbonate ﬁlter supports,41e43 and the contacts be-
tween cells and polycarbonate ﬁlter generate signiﬁcantly
increased resistance on top of the resistance imposed by
TJs.44 In our system, cells were cultured on gold-plated mi-
croelectrodes, and the value we obtained contains little cell-
substrate component.44
We also found that p120 ablation in alveoli type II cells
resulted in increased production of the surfactant proteins Sp-
B, Sp-C, and Sp-D, suggesting that p120 modulates the
production of these proteins important for innate immunity.
Sp-D plays a protective role against lung infection, allergy,
asthma, and inﬂammation by modulating host defense and
inﬂammation.23,45,46 Sp-D can bind to bacteria, viruses, and
dead cells to enhance uptake by macrophages.47 It can also
modulate the production of inﬂammatory mediators by
binding to cell surface receptors, including SP-A receptor
210, TLR2, TLR4, and signal-inhibitory protein.23 Sp-D
mutant mice exhibit delayed microbial clearance and
deregulated expression of proinﬂammatory cytokines.47 The
mechanisms that underlie the overproduction of surfactant
proteins by mutant type II cells are unclear; however, because
p120 is coupled to the transcription factor Kaiso,48 it is
possible that unchecked Kaiso activity in p120-deﬁcient type
II cells transcriptionally increases the generation of these
surfactant proteins. Augmented Sp-D expression may itself
have a role in the pathogenesis of the lung inﬂammation
observed in p120EKO mice. Sp-D binds and activates
TLR449; thus, the observed increases of both Sp-D and TLR4
could synergistically contribute to the severe inﬂammation
observed in the lungs of p120EKO mice.The American Journal of Pathology - ajp.amjpathol.orgOur ﬁndings add support to the role of p120 as an
indispensable immune modulator perhaps because it con-
nects the AJs to innate immunity.50e52 Other studies
showed that knockdown of p120 by siRNA in lung endo-
thelial cells enhances the lung inﬂammatory response
induced by lipopolysaccharide.52 p120 down-regulated
lipopolysaccharide-mediated NF-kB activation through TLR4
signaling in endothelial cells.52 Other studies using mouse
models of p120-speciﬁc depletion in the epidermis show that
these mutant mice display chronic inﬂammation which is
associated with the activation of NF-kB in the absence of
infection.50,51 In mice with conditional p120 deletion in the
intestine, epithelial barrier defects occur and generate a micro-
environment conducive to chronic inﬂammation and tumor
formation.38,53 Our ﬁndings not only reinforce these observa-
tions but also importantly show that p120 in type II alveolar
epithelial cells has a central role in regulating the host defense
functions of lungs.Acknowledgments
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